Kabuki syndrome: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
[[ | {{SI}} | ||
{{Infobox medical condition | |||
| name = Kabuki syndrome | |||
| image = [[File:Kabuki_Syndrome_9.jpg|alt=Photo of a child with Kabuki syndrome]] | |||
| caption = A child with Kabuki syndrome | |||
| field = [[Medical genetics]] | |||
| synonyms = Kabuki make-up syndrome, Niikawa-Kuroki syndrome | |||
| symptoms = [[Distinctive facial features]], [[intellectual disability]], [[growth delay]], [[skeletal abnormalities]], [[heart defects]] | |||
| onset = [[Congenital]] | |||
| duration = [[Lifelong]] | |||
| causes = [[Genetic mutation]] | |||
| risks = [[Family history]] | |||
| diagnosis = [[Clinical evaluation]], [[genetic testing]] | |||
| differential = [[Noonan syndrome]], [[CHARGE syndrome]], [[Williams syndrome]] | |||
| treatment = [[Symptomatic treatment]], [[supportive care]] | |||
| prognosis = [[Variable]] | |||
| frequency = 1 in 32,000 births | |||
}} | |||
[[file:Kabuki_syndrome.jpg|left|thumb]] [[file:Kabuki_Syndrome_6.jpg|left|thumb]] '''Kabuki syndrome''' is a rare [[genetic disorder]] characterized by distinctive facial features, growth delays, intellectual disability, and various congenital abnormalities. It was first described in 1981 by Japanese scientists [[Norio Niikawa]] and [[Yoshikazu Kuroki]], and it is also known as Niikawa-Kuroki syndrome. | |||
== Signs and Symptoms == | == Signs and Symptoms == | ||
Individuals with Kabuki syndrome often exhibit a range of physical and developmental characteristics, including: | Individuals with Kabuki syndrome often exhibit a range of physical and developmental characteristics, including: | ||
| Line 10: | Line 27: | ||
* [[Hearing loss]]. | * [[Hearing loss]]. | ||
* [[Immune system]] abnormalities, which may lead to frequent infections. | * [[Immune system]] abnormalities, which may lead to frequent infections. | ||
== Genetics == | == Genetics == | ||
Kabuki syndrome is primarily caused by mutations in the [[KMT2D]] gene, which is involved in [[histone modification]] and plays a crucial role in regulating gene expression. A smaller percentage of cases are caused by mutations in the [[KDM6A]] gene. Both genes are important for normal development and function of multiple organ systems. | Kabuki syndrome is primarily caused by mutations in the [[KMT2D]] gene, which is involved in [[histone modification]] and plays a crucial role in regulating gene expression. A smaller percentage of cases are caused by mutations in the [[KDM6A]] gene. Both genes are important for normal development and function of multiple organ systems. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of Kabuki syndrome is based on clinical evaluation, identification of characteristic features, and genetic testing to confirm mutations in the KMT2D or KDM6A genes. Early diagnosis is important for managing the various health issues associated with the syndrome. | Diagnosis of Kabuki syndrome is based on clinical evaluation, identification of characteristic features, and genetic testing to confirm mutations in the KMT2D or KDM6A genes. Early diagnosis is important for managing the various health issues associated with the syndrome. | ||
== Management == | == Management == | ||
There is no cure for Kabuki syndrome, and treatment focuses on managing symptoms and improving quality of life. This may include: | There is no cure for Kabuki syndrome, and treatment focuses on managing symptoms and improving quality of life. This may include: | ||
| Line 24: | Line 38: | ||
* Hearing aids or other interventions for hearing loss. | * Hearing aids or other interventions for hearing loss. | ||
* Regular monitoring and treatment of immune system abnormalities. | * Regular monitoring and treatment of immune system abnormalities. | ||
== Epidemiology == | == Epidemiology == | ||
Kabuki syndrome is a rare disorder, with an estimated prevalence of 1 in 32,000 to 1 in 86,000 individuals. It affects both males and females equally and has been reported in various ethnic groups worldwide. | Kabuki syndrome is a rare disorder, with an estimated prevalence of 1 in 32,000 to 1 in 86,000 individuals. It affects both males and females equally and has been reported in various ethnic groups worldwide. | ||
== History == | == History == | ||
The syndrome was first described in 1981 by Japanese scientists Norio Niikawa and Yoshikazu Kuroki, who observed a group of patients with similar facial features and developmental delays. The name "Kabuki syndrome" was chosen because the facial features of affected individuals were reminiscent of the makeup used in [[Kabuki]] theater. | The syndrome was first described in 1981 by Japanese scientists Norio Niikawa and Yoshikazu Kuroki, who observed a group of patients with similar facial features and developmental delays. The name "Kabuki syndrome" was chosen because the facial features of affected individuals were reminiscent of the makeup used in [[Kabuki]] theater. | ||
== See Also == | == See Also == | ||
* [[Genetic disorder]] | * [[Genetic disorder]] | ||
| Line 37: | Line 48: | ||
* [[Scoliosis]] | * [[Scoliosis]] | ||
* [[Hearing loss]] | * [[Hearing loss]] | ||
== References == | == References == | ||
{{Reflist}} | {{Reflist}} | ||
== External Links == | == External Links == | ||
{{Commons category|Kabuki syndrome}} | {{Commons category|Kabuki syndrome}} | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
[[Category:Syndromes]] | [[Category:Syndromes]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
Latest revision as of 01:30, 8 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Kabuki syndrome | |
|---|---|
| |
| Synonyms | Kabuki make-up syndrome, Niikawa-Kuroki syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Distinctive facial features, intellectual disability, growth delay, skeletal abnormalities, heart defects |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Clinical evaluation, genetic testing |
| Differential diagnosis | Noonan syndrome, CHARGE syndrome, Williams syndrome |
| Prevention | N/A |
| Treatment | Symptomatic treatment, supportive care |
| Medication | N/A |
| Prognosis | Variable |
| Frequency | 1 in 32,000 births |
| Deaths | N/A |


Kabuki syndrome is a rare genetic disorder characterized by distinctive facial features, growth delays, intellectual disability, and various congenital abnormalities. It was first described in 1981 by Japanese scientists Norio Niikawa and Yoshikazu Kuroki, and it is also known as Niikawa-Kuroki syndrome.
Signs and Symptoms[edit]
Individuals with Kabuki syndrome often exhibit a range of physical and developmental characteristics, including:
- Distinctive facial features such as long eyelashes, arched eyebrows, and large, prominent ears.
- Growth retardation leading to short stature.
- Intellectual disability and developmental delays.
- Skeletal abnormalities, including scoliosis and joint hypermobility.
- Congenital heart defects.
- Hearing loss.
- Immune system abnormalities, which may lead to frequent infections.
Genetics[edit]
Kabuki syndrome is primarily caused by mutations in the KMT2D gene, which is involved in histone modification and plays a crucial role in regulating gene expression. A smaller percentage of cases are caused by mutations in the KDM6A gene. Both genes are important for normal development and function of multiple organ systems.
Diagnosis[edit]
Diagnosis of Kabuki syndrome is based on clinical evaluation, identification of characteristic features, and genetic testing to confirm mutations in the KMT2D or KDM6A genes. Early diagnosis is important for managing the various health issues associated with the syndrome.
Management[edit]
There is no cure for Kabuki syndrome, and treatment focuses on managing symptoms and improving quality of life. This may include:
- Regular monitoring and treatment of congenital heart defects.
- Early intervention programs and special education to address developmental delays.
- Physical therapy to improve motor skills and manage skeletal abnormalities.
- Hearing aids or other interventions for hearing loss.
- Regular monitoring and treatment of immune system abnormalities.
Epidemiology[edit]
Kabuki syndrome is a rare disorder, with an estimated prevalence of 1 in 32,000 to 1 in 86,000 individuals. It affects both males and females equally and has been reported in various ethnic groups worldwide.
History[edit]
The syndrome was first described in 1981 by Japanese scientists Norio Niikawa and Yoshikazu Kuroki, who observed a group of patients with similar facial features and developmental delays. The name "Kabuki syndrome" was chosen because the facial features of affected individuals were reminiscent of the makeup used in Kabuki theater.
See Also[edit]
References[edit]
External Links[edit]

